Details

Title
Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Author
Dubois, Bruno; Jesús López‑Arrieta; Lipschitz, Stanley; Doskas, Triantafyllos; Spiru, Luiza; Moroz, Svitlana; Venger, Olena; Vermersch, Patrick; Moussy, Alain; Mansfield, Colin D; Olivier Hermine; Tsolaki, Magda
Pages
1
Section
Correction
Publication year
2023
Publication date
2023
Publisher
BioMed Central
e-ISSN
17589193
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s13195-023-01230-9
ProQuest document ID
2815646343
Copyright
© 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.